Search - tctmd.com

Displaying 1 - 20 of 80

Sort: Relevancy | Date

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

Presentation TCT 2016

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Presenter: Adrian P. Banning, Nick Curzen, Robert-Jan van Geuns

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Featured Lecture: A Personal Mission to Impact Cardiovascular Health: It Must Start With Children!

Presenter: Robert O. Bonow, Mitchell W. Krucoff, Valentin Fuster

November 01, 2016

News Conference News TCT 2016

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most!

Presenter: John A. Bittl, Daniel I. Simon, Salvatore Cassese

October 30, 2016

Presentation TCT 2016

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most!

Presenter: John A. Bittl, Daniel I. Simon, Laura Mauri

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann

October 30, 2016

Presentation TCT 2016

Case #1: Antegrade Dissection and Reentry: Stingray Is Not STAR

Presenter: Colm Hanratty, Simon J. Walsh, James C. Spratt

October 30, 2016

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

Presentation TCT 2015

Evolution of ADR Techniques: From STAR to Stingray

Presenter: J. Aaron Grantham, Ashish Pershad

October 14, 2015

Presentation TCT 2015

Introduction: The Ideal BRS Candidate Patient Selection When Starting Up a BRS Program

Presenter: Antonio Colombo, Nicolas M. Van Mieghem

October 14, 2015

News Conference News TCT 2015

PFO Closure Still Attracts Controversy

Yael L. Maxwell

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

Advertisement

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Debate- Is Upper Extremity Dysfunction After Radial Access Frequent and Clinically Important? Yes, We Have to Start Paying Attention to This Phenomenon!

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Featured Lecture: A Personal Mission to Impact Cardiovascular Health: It Must Start With Children!

Interventionalists Push Transradial PCI in Wider Range of Settings, Including ACS, CTOs, and Calcified Lesions

Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI

Start With the Debate - DAPT Duration With Contemporary DES: Short DAPT For Most!

Start With the Debate - DAPT Duration With Contemporary DES: Prolonged DAPT For Most!

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Case #1: Antegrade Dissection and Reentry: Stingray Is Not STAR

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Evolution of ADR Techniques: From STAR to Stingray

Introduction: The Ideal BRS Candidate Patient Selection When Starting Up a BRS Program

PFO Closure Still Attracts Controversy

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

Companies With Innovative Technologies Compete in TCT Shark Tank

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content